Melatonin promotes skin flap survival by inhibiting ferroptosis via activation of the Nrf2/HO-1 pathway

Mi Liu , Jiacheng Hu , Jiayi Huang , Zhefeng Cai , Peng Zou , Jing Bu , Shanshan Yu , Yuxi Zhou , Xiaoqiong Jiang , Lianfang Gan , Shuhong Tian , Lei Dong , Fenzan Wu , Huiming Deng , Jian Xiao

Burns & Trauma ›› 2026, Vol. 14 ›› Issue (1) : tkag012

PDF (4781KB)
Burns & Trauma ›› 2026, Vol. 14 ›› Issue (1) :tkag012 DOI: 10.1093/burnst/tkag012
Research Article
research-article
Melatonin promotes skin flap survival by inhibiting ferroptosis via activation of the Nrf2/HO-1 pathway
Author information +
History +
PDF (4781KB)

Abstract

Background: Random skin flap application is considerably limited by postoperative complications, particularly distal tissue ischemia and necrosis. Melatonin, a molecule with well-documented antioxidant and cytoprotective properties, has shown promise in protecting ischemic tissues. However, its specific role in regulating ferroptosis during ischemic flap injury, as well as its safety and efficacy in primate models (a key step for clinical translation), remains to be systematically validated. In this study, we aimed to promote angiogenesis within flap tissue through exogenous melatonin administration and to inhibit ferroptosis to mitigate ischemia–reperfusion injury, presenting a novel strategy for enhancing flap survival rates. Methods: A random skin flap was constructed in C57BL/6J mice. After melatonin treatment for seven days, the influence of melatonin on the levels of oxidative stress, iron accumulation, and mitochondrial morphology within the skin flap tissue was assessed. We used Transwell migration assays, tube formation assays, flow cytometry, and immunofluorescence staining to determine the effects of melatonin in vitro. The ferroptosis inducer erastin was used in combination with melatonin to treat random skin flap mice and tert-butyl hydroperoxide (TBHP)–induced cellular models, and the pathway through which melatonin counteracts iron mutations was explored. Lastly, we conducted experiments using nonhuman primate models and analyzed the protective effects of melatonin on ischemic flaps in macaques, highlighting its potential for clinical translation. Results: Melatonin ameliorated the survival area of ischemic flaps in mice, enhanced angiogenesis, reduced mitochondrial damage, and also suppressed lipid peroxidation and iron ion accumulation. Melatonin attenuated TBHP-induced cell death, lipid peroxidation, and mitochondrial damage in vitro. Further mechanistic studies revealed that melatonin inhibited ferroptosis, accompanied by nuclear translocation of nuclear factor E2-related factor 2 (Nrf2), and increases the expression of downstream gene (effector) heme oxygenase-1 (HO-1). More importantly, experiments in macaques demonstrated that melatonin could enhance flap viability and angiogenesis, and exhibited a good safety profile. Conclusion: Melatonin enhanced flap viability in mice and macaques by inhibiting ferroptosis, boosting angiogenesis, and attenuating oxidative stress injury.

Keywords

Melatonin / Skin flap / Ferroptosis / Oxidative stress

Cite this article

Download citation ▾
Mi Liu, Jiacheng Hu, Jiayi Huang, Zhefeng Cai, Peng Zou, Jing Bu, Shanshan Yu, Yuxi Zhou, Xiaoqiong Jiang, Lianfang Gan, Shuhong Tian, Lei Dong, Fenzan Wu, Huiming Deng, Jian Xiao. Melatonin promotes skin flap survival by inhibiting ferroptosis via activation of the Nrf2/HO-1 pathway. Burns & Trauma, 2026, 14 (1) : tkag012 DOI:10.1093/burnst/tkag012

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Pascal W, Gotowiec M, Smolinski A, Suchecki M, Kopka M, Pascal AM. et al. Biologic brachytherapy: genetically modified surgical flap as a therapeutic tool-a systematic review of animal studies. Int J Mol Sci 2024; 25:1-37. https://doi.org/10.3390/ijms251910330.

[2]

Berry CE, Le T, An N, Griffin M, Januszyk M, Kendig CB. et al. Pharmacological and cell-based treatments to increase local skin flap viability in animal models. J Transl Med 2024; 22:68. https://doi.org/10.1186/s12967-024-04882-9.

[3]

Deramo P, Rose J. Flaps: muscle and musculocutaneous. Treasure Island (FL): Statpearls, 2023.

[4]

Chu CK, Largo RD, Lee ZH, Adelman DM, Egro F, Winocour S. et al. Introduction of the l-pap flap: bipedicled, conjoined, and stacked thigh-based flaps for autologous breast reconstruction. Plast Reconstr Surg 2023; 152:1005e-10. https://doi.org/10.1097/PRS.0000000000010487.

[5]

Kozusko SD, Liu X, Riccio CA, Chang J, Boyd LC, Kokkalis Z. et al. Selecting a free flap for soft tissue coverage in lower extremity reconstruction. Injury 2019; 50:S32-9. https://doi.org/10.1016/j.injury.2019.10.045.

[6]

Takeo M, Lee W, Ito M. Wound healing and skin regeneration. Cold Spring Harb Perspect Med 2015; 5:a023267. https://doi.org/10.1101/cshperspect.a023267.

[7]

Liu Z, Chen DH, Lin ZH, Wang ZY, Peng H, Liu RT. et al. In-situ sprayed platelet-derived small extracellular vesicles for the skin flap survival by reducing panoptosis. Biomaterials 2025; 316:123001.

[8]

Li Y, Jiang QL, Van der Merwe L, Lou DH, Lin C. Preclinical efficacy of stem cell therapy for skin flap: a systematic review and meta-analysis. Stem Cell Res Ther 2021; 12:28.

[9]

Deng J, Wang K, Yang J, Wang A, Chen G, Ye M. et al. B-caryophyllene promotes the survival of random skin flaps by upregulating the pi3k/akt signaling pathway. Phytomedicine 2024; 130:155726.

[10]

Afrooghe A, Damavandi AR, Ahmadi E, Jafari RM, Dehpour AR . The current state of knowledge on how to improve skin flap survival: a review. J Plast Reconstr Aesthet Surg 2023; 82:48-57.

[11]

Toutain CE, Brouchet L, Raymond-Letron I, Vicendo P, Berges H, Favre J. et al. Prevention of skin flap necrosis by estradiol involves reperfusion of a protected vascular network. Circ Res 2009; 104:245-54. https://doi.org/10.1161/CIRCRESAHA.108.182410.

[12]

Vasey C, McBride J, Penta K. Circadian rhythm dysregulation and restoration: the role of melatonin. Nutrients 2021; 13:3480.

[13]

Beslic I, Lugovic-Mihic L, Vrtaric A, Beslic A, Skrinjar I, Hanzek M. et al. Melatonin in dermatologic allergic diseases and other skin conditions: current trends and reports. Int J Mol Sci 2023; 24:1-15.

[14]

Joseph TT, Schuch V, Hossack DJ, Chakraborty R, Johnson EL. Melatonin: the placental antioxidant and anti-inflammatory. Front Immunol 2024; 15:1339304.

[15]

Xu D, Liu L, Zhao Y, Yang L, Cheng J, Hua R. et al. Melatonin protects mouse testes from palmitic acid-induced lipotoxicity by attenuating oxidative stress and DNA damage in a sirt1-dependent manner. J Pineal Res 2020; 69:e12690. https://doi.org/10.1111/jpi.12690.

[16]

Siemionow M, Arslan E. Ischemia/reperfusion injury: a review in relation to free tissue transfers. Microsurgery 2004; 24:468-75.

[17]

Zhao XY, Shan J, Qian HY, Jin X, Sun YW, Xing JH. et al. Caffeic acid-vanadium nanozymes treat skin flap ischemia-reperfusion injury through macrophage reprogramming and the upregulation of x-linked inhibitors of apoptotic proteins. Acta Pharm Sin B 2025; 15:592-610. https://doi.org/10.1016/j.apsb.2024.08.022.

[18]

Gurlek A, Aydogan H, Parlakpinar H, Bay-Karabulut A, Celik M, Sezgin N. et al. Protective effect of melatonin on random pattern skin flap necrosis in pinealectomized rat. J Pineal Res 2004; 36:58-63.

[19]

Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 2021; 22:266-82. https://doi.org/10.1038/s41580-020-00324-8.

[20]

Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res 2021; 31:107-25. https://doi.org/10.1038/s41422-020-00441-1.

[21]

Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 2022; 82:2215-27. https://doi.org/10.1016/j.molcel.2022.03.022.

[22]

Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ. et al. Inactivation of the ferroptosis regulator gpx4 triggers acute renal failure in mice. Nat Cell Biol 2014; 16:1180-91. https://doi.org/10.1038/ncb3064.

[23]

Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther 2023; 8:372.

[24]

Wang X, Chen T, Chen S, Zhang J, Cai L, Liu C. et al. Sting aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting gpx4 for autophagic degradation. Signal Transduct Target Ther 2025; 10:136.

[25]

Sun XF, Ou ZH, Chen RC, Niu XH, Chen D, Kang R. et al. Activation of the p62-keap1-nrf2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 2016; 63:173-84. https://doi.org/10.1002/hep.28251.

[26]

Lin S, Wu B, Hu X, Lu H. Sirtuin 4 (sirt4) downregulation contributes to chondrocyte senescence and osteoarthritis via mediating mitochondrial dysfunction. Int J Biol Sci 2024; 20:1256-78. https://doi.org/10.7150/ijbs.85585.

[27]

Wang J, Yang J, Fang Y, Lou C, Yu H, Li Y. et al. Vinpocetine protects against osteoarthritis by inhibiting ferroptosis and extracellular matrix degradation via activation of the nrf2/gpx4 pathway. Phytomedicine 2024; 135:156115.

[28]

Fu T, Sullivan DP, Gonzalez AM, Haynes ME, Dalal PJ, Rutledge NS. et al. Mechanotransduction via endothelial adhesion molecule cd31 initiates transmigration and reveals a role for vegfr2 in diapedesis. Immunity 2023; 56:2311-24.

[29]

Mori M, Sakamoto A, Kawakami R, Guo L, Slenders L, Mosquera JV. et al. Cd163(+) macrophages induce endothelial-to-mesenchymal transition in atheroma. Circ Res 2024; 135:e4-23. https://doi.org/10.1161/CIRCRESAHA.123.324082.

[30]

Vestweber D. Ve-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008; 28:223-32.

[31]

van Hinsbergh VW, Engelse MA, Quax PH. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 2006; 26:716-28.

[32]

Wu J, Han W, Zhang Y, Li S, Qin T, Huang Z. et al. Glutamine mitigates oxidative stress-induced matrix degradation, ferroptosis, and pyroptosis in nucleus pulposus cells via deubiquitinating and stabilizing nrf2. Antioxid Redox Signal 2024; 41:278-95. https://doi.org/10.1089/ars.2023.0384.

[33]

Lee HW, Xu Y, He L, Choi W, Gonzalez D, Jin SW. et al. Role of venous endothelial cells in developmental and pathologic angiogenesis. Circulation 2021; 144:1308-22. https://doi.org/10.1161/CIRCULATIONAHA.121.054071.

[34]

Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol 2021; 18:280-96. https://doi.org/10.1038/s41571-020-00462-0.

[35]

Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 2009; 47:344-56.

[36]

Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D. et al. Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal 2015; 23:1144-70. https://doi.org/10.1089/ars.2015.6317.

[37]

Susan WSL, Shi Y. The glycolytic process in endothelial cells and its implications. Acta Pharmacol Sin 2022; 43:251-9.

[38]

Huang G, Cai Y, Ren M, Zhang X, Fu Y, Cheng R. et al. Salidroside sensitizes triple-negative breast cancer to ferroptosis by scd1-mediated lipogenesis and ncoa4-mediated ferritinophagy. J Adv Res 2024; 74:589-607.

[39]

Liu J, Pang SY, Zhou SY, He QY, Zhao RY, Qu Y. et al. Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the hmgb1/nrf2/ho-1 pathway. Redox Biol 2024; 76:103342.

[40]

Wei R, Zhao Y, Wang J, Yang X, Li S, Wang Y. et al. Tagitinin c induces ferroptosis through perk-nrf2-ho-1 signaling pathway in colorectal cancer cells. Int J Biol Sci 2021; 17:2703-17. https://doi.org/10.7150/ijbs.59404.

[41]

Hu M, Belloni R, Ladowski J, Schiliro D, Martinino A, Schwalb A. et al. Cryopreserved skin transplantation in a nonhuman primate model. Transplant Proc 2025; 57:1201-4. https://doi.org/10.1016/j.transproceed.2025.06.002.

[42]

Harding J, Roberts RM, Mirochnitchenko O. Large animal models for stem cell therapy. Stem Cell Res Ther 2013; 4:23. https://doi.org/10.1186/scrt171.

[43]

Kalsi R, Messner F, Brandacher G. Skin xenotransplantation: technological advances and future directions. Curr Opin Organ Transplant 2020; 25:464-76. https://doi.org/10.1097/MOT.0000000000000798.

[44]

Maciel-Miranda A, Morris SF, Hallock GG . Local flaps, including pedicled perforator flaps: anatomy, technique, and applications. Plast Reconstr Surg 2013; 131:896e-11. https://doi.org/10.1097/PRS.0b013e31828bd89f.

[45]

Zhang L, Yu G, Yu Q, Wang L, Wu L, Tao Z. et al. Baicalin promotes random-pattern skin flap survival by inducing autophagy via ampk-regulated tfeb nuclear transcription. Phytother Res 2023; 37:3926-38. https://doi.org/10.1002/ptr.7849.

[46]

Wu H, Ding J, Li S, Lin J, Jiang R, Lin C. et al. Metformin promotes the survival of random-pattern skin flaps by inducing autophagy via the ampk-mtor-tfeb signaling pathway. Int J Biol Sci 2019; 15:325-40. https://doi.org/10.7150/ijbs.29009.

[47]

Zhang H, Li C, Wen D, Li R, Lu S, Xu R. et al. Melatonin improves the quality of maternally aged oocytes by maintaining intercellular communication and antioxidant metabolite supply. Redox Biol 2022; 49:102215.

[48]

Chitimus DM, Popescu MR, Voiculescu SE, Panaitescu AM, Pavel B, Zagrean L. et al. Melatonin’s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules 2020;10:10. https://doi.org/10.3390/biom10091211.

[49]

Kobroob A, Kongkaew A, Wongmekiat O. Melatonin reduces aggravation of renal ischemia-reperfusion injury in obese rats by maintaining mitochondrial homeostasis and integrity through ampk/pgc-1alpha/sirt3/sod2 activation. Curr Issues Mol Biol 2023; 45:8239-54. https://doi.org/10.3390/cimb45100520.

[50]

Ma ZQ, Xin ZL, Di WC, Yan XL, Li XF, Reiter RJ. et al. Melatonin and mitochondrial function during ischemia/reperfusion injury. Cell Mol Life Sci 2017; 74:3989-98. https://doi.org/10.1007/s00018-017-2618-6.

[51]

Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011; 146:873-87. https://doi.org/10.1016/j.cell.2011.08.039.

[52]

Schafer M, Werner S. Oxidative stress in normal and impaired wound repair. Pharmacol Res 2008; 58:165-71. https://doi.org/10.1016/j.phrs.2008.06.004.

[53]

Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol 2015; 4:180-3. https://doi.org/10.1016/j.redox.2015.01.002.

[54]

Ioannidis M, Tjepkema J, Uitbeijerse MRP, van den Bogaart G. Immunomodulatory effects of 4-hydroxynonenal. Redox Biol 2025; 85:103719.

[55]

Yehia A, Abulseoud OA. Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-covid-19 trajectory of accelerated brain aging and neurodegeneration. Mol Neurodegener 2024; 19:36.

[56]

Wang ZJ, Shen N, Wang Z, Yu L, Yang S, Wang Y. et al. Trim3 facilitates ferroptosis in non-small cell lung cancer through promoting slc7a11/xct k11-linked ubiquitination and degradation. Cell Death Differ 2024; 31:53-64. https://doi.org/10.1038/s41418-023-01239-5.

[57]

Fan R, Deng A, Lin R, Zhang S, Cheng C, Zhuang J. et al. A platinum(iv)-artesunate complex triggers ferroptosis by boosting cytoplasmic and mitochondrial lipid peroxidation to enhance tumor immunotherapy. MedComm 2020; 5:e570. https://doi.org/10.1002/mco2.570.

[58]

Hai Y, Fan R, Zhao T, Lin R, Zhuang J, Deng A. et al. A novel mitochondria-targeting dhodh inhibitor induces robust ferroptosis and alleviates immune suppression. Pharmacol Res 2024; 202:107115.

PDF (4781KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉